Aptevo Therapeutics Inc Earning Date (APVO)

USA |NASDAQ |USD

APVO Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Mar 31, 2022 (est) Dec 31, 2021 - $-1.43 $-1.92
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Mar 31, 2022 (est) Dec 31, 2021 - $3.10M $2.37M

Aptevo Therapeutics Inc's next estimated earnings date (based on same quarter last year's date) is Mar 31, 2022 for the fiscal quarter ending Dec 31, 2021.

APVO Earnings Date & History Chart

APVO Earnings & Revenue Forecast

APVO Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Mar 2022 1 $-1.02 $-1.02 $-1.02
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 1 $-4.23 $-4.23 $-4.23

APVO Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Mar 2022 1 / 0 $-1.81 $-1.81 $-1.81
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2022 2 / 0 $-5.18 $-5.18 $-4.84

APVO Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Mar 2022 2 $3.65M $3.30M $4.00M
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 2 $15.90M $13.80M $18.00M

APVO Earnings Date & Revenue History

APVO Earnings History

|
Show More
Show More

APVO Revenue History

|
Show More
Show More

Aptevo Therapeutics Inc Next Earnings Date & Report

APVO Nov 2021 (FQ) Earnings Date & Report Preview

APVO's next estimated earnings date (based on same quarter last year's report date) is Mar 31, 2022 for the fiscal quarter ending Dec 31, 2021.

Aptevo Therapeutics Inc Previous Earnings Dates & Reports

APVO Previous Earnings Date & Report Recap: Sep 2021 (FQ)

Aptevo Therapeutics Inc's previous earnings date was Nov 12, 2021 for its fiscal quarter ended Sep 30, 2021.

APVO's earnings per share (EPS) was $-1.43, beating the consensus analysts forecast of $-1.48 by 3.05%.

The EPS was higher than the previous fiscal quarter (Jun 2021) by -18.29%, and higher than the same period a year before (Sep 2020) by -31.90%.

Revenues were $3.10M, worse than the forecast of $3.65M by -15.18%, down by -0.45% from the previous quarter , and up by 111.62% from the same period last year.

The company reported a net income of $-7.00M.

Free cash flow for the quarter was $-18.39M , compared to $-5.44M last quarter and $-7.39M a year before.

APVO Previous Earnings Date & Report Recap: Dec 2020 (FY)

Aptevo Therapeutics Inc's previous annual earnings date was Mar 31, 2021 for its fiscal year ended Dec 31, 2020.

APVO's earnings per share (EPS) was $-5.23, missing the consensus analysts forecast of $-4.56 by 14.69% , and higher than the previous year's EPS (Dec 2019) by -62.27%.

Revenues were $4.31M, better than the forecast of $3.68M by 17.09%, and down by -86.71% from previous year's revenue.

The company reported a net income of $-17.75M.

Aptevo Therapeutics Inc reported a free cash flow of $-29.41M for its fiscal year, compared to $-42.54M a year ago.

The company ended the fiscal year with $10.00M in total debt, a decrease of -56.88% compared to the previous year.